Reference
Medicines and Healthcare products Regulatory Agency (UK). Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy. Internet Document : 27 Jan 2020. Available from: URL: https://www.gov.uk/drug-safety-update/ondansetron-small-increased-risk-of-oral-clefts-following-use-in-the-first-12-weeks-of-pregnancy
Rights and permissions
About this article
Cite this article
Ondansetron: small increased risk of orofacial malformations. Reactions Weekly 1791, 2 (2020). https://doi.org/10.1007/s40278-020-74847-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74847-6